Bing Ni

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Endoplasmic Reticulum Stress

Top Venues

Cell death discovery

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Chuanxu Wang, Rui Dong, Feicheng Yang, Lu Zheng, Yingling Liu, Yue Yan, Mengjie Zhang, Bing Ni, Jing Li
LARP4B promotes hepatocellular carcinoma progression and impairs sorafenib efficacy by activating SPINK1-mediated EGFR pathway. Cell death discovery 10 (1) (2024)
Chuanxu Wang, Rui Dong, Feicheng Yang, Lu Zheng, Yingling Liu, Yue Yan, Mengjie Zhang, Bing Ni, Jing Li
LARP4B promotes hepatocellular carcinoma progression and impairs sorafenib efficacy by activating SPINK1-mediated EGFR pathway. Cell death discovery 10 (1) (2024)
Chuanxu Wang, Rui Dong, Feicheng Yang, Lu Zheng, Yingling Liu, Yue Yan, Mengjie Zhang, Bing Ni, Jing Li
LARP4B promotes hepatocellular carcinoma progression and impairs sorafenib efficacy by activating SPINK1-mediated EGFR pathway. Cell death discovery 10 (1) (2024)
Yi Tian, Chao Han, Zhiyuan Wei, Hui Dong, Xiaohe Shen, Yiqiang Cui, Xiaolan Fu, Zhiqiang Tian, Shufeng Wang, Jian Zhou, Di Yang, Yi Sun, Jizhao Yuan, Bing Ni, Yu-Zhang Wu
SOX-5 activates a novel RORγt enhancer to facilitate experimental autoimmune encephalomyelitis by promoting Th17 cell differentiation. Nature communications 12 (1) (2021)